Nanoflowers as Next Generation Catalysts
Nanoflowers are nanostructures which, when viewed with scanning electron microscopy, resemble flowers or trees. They are of interest to scientists because of their high stability and enhanced efficiency. Their applications range from optoelectronics devices or sensors, catalysis and solar cells as well as uses in nanotechnology. Associate Professor İsmail Öçsoy is a teacher and researcher... Read more
24 Hours of Life Science Conference
On June 2, 2021, JEOL will focus on advances in life science research using electron microscopy in its “24 Hours of Life Science” conference. Twenty-four different sessions throughout the full day will cover topics including: – Connectomics and the study of complete volumes of tissues or materials captured at high resolution– Correlative microscopy using light... Read more
European Commission approves Venclyxto-based combinations for adults with newly diagnosed acute myeloid leukaemia who are ineligible for intensive chemotherapy
With hypomethylating agents significantly improved complete response rates in certain adults with newly diagnosed acute myeloid leukaemia In the VIALE-A study, Venclyxto plus azacitidine significantly improved overall survival in patients ineligible for intensive chemotherapy, a patient population who typically have a five-year overall survival rate of less than 10%1 Study data reinforces the potential of... Read more
MKS Instruments to Participate at Upcoming Investor Conferences
ANDOVER, Mass., May 24, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, announced today that company management will be presenting at the following investor conferences: Cowen 49 th Annual Read more
Pacific Biosciences Grants Equity Incentive Award to New Employee
MENLO PARK, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 240,000 shares of... Read more
Brooks to Participate in the Jefferies Virtual Healthcare Conference
CHELMSFORD, Mass., May 20, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 which includes a webcast beginning at 9:00 a.m. ET. The live webcast can be accessed through the Brooks investor relations website at www.brooks.investorroom.com/events. A replay of the... Read more
Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities
Australian National Phenome Centre Integrates Quantitative NMR and MS Assay Platform for Risk Assessment and Longitudinal Monitoring of Post-Acute COVID-19 Syndrome (PACS) PERTH, Australia–(BUSINESS WIRE)– A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute... Read more
Thermo Fisher Scientific Accelerates Complex Materials Research at Monash University with Specialized 300kV (S)TEM Microscope
Thermo Fisher Scientific Accelerates Complex Materials Research at Monash University with Specialized 300kV (S)TEM Microscope HILLSBORO, Ore., May 20, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, has developed a custom-built high-resolution scanning transmission electron microscope ((S)TEM) to support advanced materials research at Monash University. The instrument is being installed in the... Read more
Pivotal Phase III data at ASCO show Roche’s Tecentriq helps certain people with early lung cancer live significantly longer without their disease returning
Tecentriq improved disease-free survival by more than one-third in people with PD-L1-positive resectable early-stage lung cancer, compared with best supportive care First and only cancer immunotherapy to show positive Phase III results in the adjuvant lung cancer setting New adjuvant treatment options are urgently needed in early lung cancer to help the approximately 50% of... Read more